世界の関節炎モノクローナル抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Arthritis Monoclonal Antibodies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3853 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、関節炎モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（レミケード、ヒュミラ、エンブレル、リツキサン、オレンシア、アクテムラ、シンポニ、シムジア）、用途別市場規模（関節リウマチ、変形性関節症、乾癬性関節炎、強直性脊椎炎、線維筋痛症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・関節炎モノクローナル抗体の市場動向 ・企業の競争状況、市場シェア ・関節炎モノクローナル抗体の種類別市場規模と予測2016-2027（レミケード、ヒュミラ、エンブレル、リツキサン、オレンシア、アクテムラ、シンポニ、シムジア） ・関節炎モノクローナル抗体の用途別市場規模と予測2016-2027（関節リウマチ、変形性関節症、乾癬性関節炎、強直性脊椎炎、線維筋痛症、その他） ・関節炎モノクローナル抗体の北米市場規模2016-2027（アメリカ、カナダ） ・関節炎モノクローナル抗体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・関節炎モノクローナル抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・関節炎モノクローナル抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・関節炎モノクローナル抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc、F. Hoffmann-La Roche Ltd、Novartis、Johnson & Johnson(Janssen)、Pfizer Inc、Mylan、Genentech、GSK、AstraZeneca PLC） ・結論

Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases

Market Analysis and Insights: Global Arthritis Monoclonal Antibodies Market
The global Arthritis Monoclonal Antibodies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Arthritis Monoclonal Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Arthritis Monoclonal Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Arthritis Monoclonal Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Arthritis Monoclonal Antibodies market.

Global Arthritis Monoclonal Antibodies Scope and Market Size
Arthritis Monoclonal Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Arthritis Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Remicade
Humira
Enbrel
Rituxan
Orencia
Actemra
Simponi
Cimzia

Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie Inc
F. Hoffmann-La Roche Ltd
Novartis
Johnson & Johnson(Janssen)
Pfizer Inc
Mylan
Genentech
GSK
AstraZeneca PLC

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Remicade
1.2.3 Humira
1.2.4 Enbrel
1.2.5 Rituxan
1.2.6 Orencia
1.2.7 Actemra
1.2.8 Simponi
1.2.9 Cimzia
1.3 Market by Application
1.3.1 Global Arthritis Monoclonal Antibodies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Arthritis Monoclonal Antibodies Market Perspective (2016-2027)
2.2 Arthritis Monoclonal Antibodies Growth Trends by Regions
2.2.1 Arthritis Monoclonal Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Arthritis Monoclonal Antibodies Historic Market Share by Regions (2016-2021)
2.2.3 Arthritis Monoclonal Antibodies Forecasted Market Size by Regions (2022-2027)
2.3 Arthritis Monoclonal Antibodies Industry Dynamic
2.3.1 Arthritis Monoclonal Antibodies Market Trends
2.3.2 Arthritis Monoclonal Antibodies Market Drivers
2.3.3 Arthritis Monoclonal Antibodies Market Challenges
2.3.4 Arthritis Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue
3.1.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue (2016-2021)
3.1.2 Global Arthritis Monoclonal Antibodies Revenue Market Share by Players (2016-2021)
3.2 Global Arthritis Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Arthritis Monoclonal Antibodies Revenue
3.4 Global Arthritis Monoclonal Antibodies Market Concentration Ratio
3.4.1 Global Arthritis Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arthritis Monoclonal Antibodies Revenue in 2020
3.5 Arthritis Monoclonal Antibodies Key Players Head office and Area Served
3.6 Key Players Arthritis Monoclonal Antibodies Product Solution and Service
3.7 Date of Enter into Arthritis Monoclonal Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Arthritis Monoclonal Antibodies Breakdown Data by Type
4.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Type (2016-2021)
4.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2022-2027)

5 Arthritis Monoclonal Antibodies Breakdown Data by Application
5.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Application (2016-2021)
5.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Arthritis Monoclonal Antibodies Market Size (2016-2027)
6.2 North America Arthritis Monoclonal Antibodies Market Size by Type
6.2.1 North America Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
6.2.2 North America Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
6.2.3 North America Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
6.3 North America Arthritis Monoclonal Antibodies Market Size by Application
6.3.1 North America Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
6.3.2 North America Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
6.3.3 North America Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
6.4 North America Arthritis Monoclonal Antibodies Market Size by Country
6.4.1 North America Arthritis Monoclonal Antibodies Market Size by Country (2016-2021)
6.4.2 North America Arthritis Monoclonal Antibodies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Arthritis Monoclonal Antibodies Market Size (2016-2027)
7.2 Europe Arthritis Monoclonal Antibodies Market Size by Type
7.2.1 Europe Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
7.2.2 Europe Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
7.2.3 Europe Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
7.3 Europe Arthritis Monoclonal Antibodies Market Size by Application
7.3.1 Europe Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
7.3.2 Europe Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
7.3.3 Europe Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
7.4 Europe Arthritis Monoclonal Antibodies Market Size by Country
7.4.1 Europe Arthritis Monoclonal Antibodies Market Size by Country (2016-2021)
7.4.2 Europe Arthritis Monoclonal Antibodies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size (2016-2027)
8.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type
8.2.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
8.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application
8.3.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
8.4 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region
8.4.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Arthritis Monoclonal Antibodies Market Size (2016-2027)
9.2 Latin America Arthritis Monoclonal Antibodies Market Size by Type
9.2.1 Latin America Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
9.2.2 Latin America Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
9.2.3 Latin America Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
9.3 Latin America Arthritis Monoclonal Antibodies Market Size by Application
9.3.1 Latin America Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
9.3.2 Latin America Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
9.3.3 Latin America Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
9.4 Latin America Arthritis Monoclonal Antibodies Market Size by Country
9.4.1 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2016-2021)
9.4.2 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size (2016-2027)
10.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type
10.2.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2016-2027)
10.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application
10.3.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2016-2027)
10.4 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country
10.4.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Arthritis Monoclonal Antibodies Introduction
11.1.4 AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.1.5 AbbVie Inc Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Arthritis Monoclonal Antibodies Introduction
11.3.4 Novartis Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson(Janssen)
11.4.1 Johnson & Johnson(Janssen) Company Details
11.4.2 Johnson & Johnson(Janssen) Business Overview
11.4.3 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Introduction
11.4.4 Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.4.5 Johnson & Johnson(Janssen) Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Details
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc Arthritis Monoclonal Antibodies Introduction
11.5.4 Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.5.5 Pfizer Inc Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Arthritis Monoclonal Antibodies Introduction
11.6.4 Mylan Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech Arthritis Monoclonal Antibodies Introduction
11.7.4 Genentech Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.7.5 Genentech Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Arthritis Monoclonal Antibodies Introduction
11.8.4 GSK Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.8.5 GSK Recent Development
11.9 AstraZeneca PLC
11.9.1 AstraZeneca PLC Company Details
11.9.2 AstraZeneca PLC Business Overview
11.9.3 AstraZeneca PLC Arthritis Monoclonal Antibodies Introduction
11.9.4 AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2016-2021)
11.9.5 AstraZeneca PLC Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Remicade
Table 3. Key Players of Humira
Table 4. Key Players of Enbrel
Table 5. Key Players of Rituxan
Table 6. Key Players of Orencia
Table 7. Key Players of Actemra
Table 8. Key Players of Simponi
Table 9. Key Players of Cimzia
Table 10. Global Arthritis Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Arthritis Monoclonal Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Arthritis Monoclonal Antibodies Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Arthritis Monoclonal Antibodies Market Share by Regions (2016-2021)
Table 14. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Arthritis Monoclonal Antibodies Market Share by Regions (2022-2027)
Table 16. Arthritis Monoclonal Antibodies Market Trends
Table 17. Arthritis Monoclonal Antibodies Market Drivers
Table 18. Arthritis Monoclonal Antibodies Market Challenges
Table 19. Arthritis Monoclonal Antibodies Market Restraints
Table 20. Global Arthritis Monoclonal Antibodies Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Arthritis Monoclonal Antibodies Market Share by Players (2016-2021)
Table 22. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Monoclonal Antibodies as of 2020)
Table 23. Ranking of Global Top Arthritis Monoclonal Antibodies Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Arthritis Monoclonal Antibodies Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Arthritis Monoclonal Antibodies Product Solution and Service
Table 27. Date of Enter into Arthritis Monoclonal Antibodies Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Table 31. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Arthritis Monoclonal Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2016-2021)
Table 35. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Arthritis Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Arthritis Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Arthritis Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Arthritis Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 67. AbbVie Inc Company Details
Table 68. AbbVie Inc Business Overview
Table 69. AbbVie Inc Arthritis Monoclonal Antibodies Product
Table 70. AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 71. AbbVie Inc Recent Development
Table 72. F. Hoffmann-La Roche Ltd Company Details
Table 73. F. Hoffmann-La Roche Ltd Business Overview
Table 74. F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Product
Table 75. F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 76. F. Hoffmann-La Roche Ltd Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Arthritis Monoclonal Antibodies Product
Table 80. Novartis Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Johnson & Johnson(Janssen) Company Details
Table 83. Johnson & Johnson(Janssen) Business Overview
Table 84. Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Product
Table 85. Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson(Janssen) Recent Development
Table 87. Pfizer Inc Company Details
Table 88. Pfizer Inc Business Overview
Table 89. Pfizer Inc Arthritis Monoclonal Antibodies Product
Table 90. Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 91. Pfizer Inc Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Arthritis Monoclonal Antibodies Product
Table 95. Mylan Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 96. Mylan Recent Development
Table 97. Genentech Company Details
Table 98. Genentech Business Overview
Table 99. Genentech Arthritis Monoclonal Antibodies Product
Table 100. Genentech Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 101. Genentech Recent Development
Table 102. GSK Company Details
Table 103. GSK Business Overview
Table 104. GSK Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 105. GSK Recent Development
Table 106. AstraZeneca PLC Company Details
Table 107. AstraZeneca PLC Business Overview
Table 108. AstraZeneca PLC Arthritis Monoclonal Antibodies Product
Table 109. AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 110. AstraZeneca PLC Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Arthritis Monoclonal Antibodies Market Share by Type: 2020 VS 2027
Figure 2. Remicade Features
Figure 3. Humira Features
Figure 4. Enbrel Features
Figure 5. Rituxan Features
Figure 6. Orencia Features
Figure 7. Actemra Features
Figure 8. Simponi Features
Figure 9. Cimzia Features
Figure 10. Global Arthritis Monoclonal Antibodies Market Share by Application: 2020 VS 2027
Figure 11. Rheumatoid Arthritis Case Studies
Figure 12. Osteoarthritis Case Studies
Figure 13. Psoriatic Arthritis Case Studies
Figure 14. Ankylosing Spondylitis Case Studies
Figure 15. Fibromyalgia Case Studies
Figure 16. Others Case Studies
Figure 17. Arthritis Monoclonal Antibodies Report Years Considered
Figure 18. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Arthritis Monoclonal Antibodies Market Share by Regions: 2020 VS 2027
Figure 21. Global Arthritis Monoclonal Antibodies Market Share by Regions (2022-2027)
Figure 22. Global Arthritis Monoclonal Antibodies Market Share by Players in 2020
Figure 23. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Monoclonal Antibodies as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Arthritis Monoclonal Antibodies Revenue in 2020
Figure 25. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Figure 26. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2022-2027)
Figure 27. North America Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 29. North America Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 30. North America Arthritis Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 31. United States Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 35. Europe Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 36. Europe Arthritis Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 37. Germany Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Region (2016-2027)
Figure 47. China Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 55. Latin America Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 56. Latin America Arthritis Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 57. Mexico Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 63. Turkey Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Arthritis Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. AbbVie Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 67. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 69. Johnson & Johnson(Janssen) Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 70. Pfizer Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 71. Mylan Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 72. Genentech Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 73. GSK Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 74. AstraZeneca PLC Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---